Monday November 23 2009 | Biotechnology feed | All feeds
|
|
PLANTON GmbH
Download detailed PDF Members: Infectious diseases are the most frequent causes of death. Microbial resistance to antibiotics is an increasing problem in medical treatment and thus an important focus in pharmaceutical research. PLANTON develops and produces a novel class of antiinfectiva – antimicrobial peptides. These molecules have a strong antibiotic efficacy and a special mechanism avoiding resistance of human pathogens. For the antimicrobial treatment this new class is a promising alternative (PMP = Plant Made Pharmaceuticals).Therefore, the company established a production system based on green plants. The production of antimicrobial peptides in plants is highly efficient, feasible at low costs and safe.
This page has been viewed 227 times since April 2007, the link to the organisation's website has been followed 37 times Search for more companies in Kiel This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for PLANTON GmbH | |||||||||||||||||||||||||||||||||||||||||
|